Z-0352-2024 Class II Ongoing
FDA device recall Z-0352-2024 was initiated by Roche Diagnostics Operations, Inc. on Oct 3, 2023 and is designated Class II. Reason for recall: Elevated results were detected with Li-heparin plasma samples when compared to citrated plasma samples. The recall status is ongoing. Affected quantity: 5,263 kits.
Recall details
- Product Type
- Devices
- Report Date
- Nov 29, 2023
- Initiation Date
- Oct 3, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 5,263 kits
Product description
Tina-quant D-Dimer Test System, Fibrinogen/Fibrin Degradation Products Assay, Material Numbers 03001245322 - (cobas c 311, 501 and 502; INTEGRA 400 plus), 08105618190 - (cobas c 303 and 503)
Reason for recall
Elevated results were detected with Li-heparin plasma samples when compared to citrated plasma samples.
Distribution pattern
US Nationwide distribution.
Code information
All Lots Affected. UDI: 04015630914593 - (cobas c 311, 501 and 502; INTEGRA 400 plus) UDI: 07613336133651 - (cobas c 303 and 503)
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0352-2024
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026